Chem. Pharm. Bull. 54(8) 1150—1154 (2006)


DNA is the primary intracellular target of anticancer drugs due to the interaction between small molecules and DNA, which cause DNA damage in cancer cells, blocking the division of cancer cells and resulting in cell death. Of these studies, the interaction of transition metal complexes containing multidentate aromatic ligands, with DNA has gained much… (More)


9 Figures and Tables